DK137837C - Fremgangsmaade til fremstilling af delta9(11)-5alfa-20-ketopregnener - Google Patents

Fremgangsmaade til fremstilling af delta9(11)-5alfa-20-ketopregnener

Info

Publication number
DK137837C
DK137837C DK260976A DK260976A DK137837C DK 137837 C DK137837 C DK 137837C DK 260976 A DK260976 A DK 260976A DK 260976 A DK260976 A DK 260976A DK 137837 C DK137837 C DK 137837C
Authority
DK
Denmark
Prior art keywords
5alfa
delta9
calculators
keto
preparing
Prior art date
Application number
DK260976A
Other languages
Danish (da)
English (en)
Other versions
DK260976A (da
DK137837B (da
Inventor
U Kerb
R Wiechert
O Engelfried
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK260976A publication Critical patent/DK260976A/da
Publication of DK137837B publication Critical patent/DK137837B/da
Application granted granted Critical
Publication of DK137837C publication Critical patent/DK137837C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
DK260976A 1975-06-11 1976-06-11 Fremgangsmaade til fremstilling af delta9(11)-5alfa-20-ketopregnener DK137837C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2526373A DE2526373C2 (de) 1975-06-11 1975-06-11 Verfahren zur Herstellung von Δ↑9↑↑(↑↑1↑↑1↑↑)↑-5α-20-Ketosteroiden

Publications (3)

Publication Number Publication Date
DK260976A DK260976A (da) 1976-12-12
DK137837B DK137837B (da) 1978-05-16
DK137837C true DK137837C (da) 1978-10-23

Family

ID=5948981

Family Applications (1)

Application Number Title Priority Date Filing Date
DK260976A DK137837C (da) 1975-06-11 1976-06-11 Fremgangsmaade til fremstilling af delta9(11)-5alfa-20-ketopregnener

Country Status (10)

Country Link
US (1) US4061661A (xx)
JP (1) JPS51149260A (xx)
CH (1) CH620452A5 (xx)
DD (1) DD125699A5 (xx)
DE (1) DE2526373C2 (xx)
DK (1) DK137837C (xx)
FR (1) FR2314197A1 (xx)
GB (1) GB1554901A (xx)
HU (1) HU174227B (xx)
NL (1) NL7606137A (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2748442C3 (de) * 1977-10-26 1981-08-27 Schering Ag Berlin Und Bergkamen, 1000 Berlin 17α-(3-Jodbenzoyloxy)-9α -chlor4-pregnen-3.20-dione, Zwischenprodukte und Verfahren zu ihrer Herstellung, 9α -chlor-17α, 21-dihydroxy-1,4-pregnadien-3,20-dion und dieses enthaltende Arzneimittel
US4252729A (en) * 1978-05-12 1981-02-24 Hoffmann-La Roche Inc. Steroids and process for their manufacture
US4252719A (en) * 1978-08-17 1981-02-24 Research Corporation Steroid conversion method and products produced thereby
DE2929558C2 (de) * 1979-07-18 1982-03-11 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von Δ↑9↑↑(↑↑1↑↑1↑↑)↑ und/oder Δ↑1↑↑6↑ ungesättigten Steroiden
US4328162A (en) * 1980-09-05 1982-05-04 Eastman Kodak Company Process for preparing 9,11-unsaturated steroidal compound from the corresponding saturated steroidal compound
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
EP3572417A3 (en) 2011-10-14 2020-03-25 Sage Therapeutics, Inc. 3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof
KR102239541B1 (ko) 2013-04-17 2021-04-14 세이지 테라퓨틱스, 인크. 19-노르 c3,3-이치환된 c21-n-피라졸릴 스테로이드 및 그의 사용 방법
RU2700264C2 (ru) 2013-04-17 2019-09-16 Сейдж Терапьютикс, Инк. 19-нор нейроактивные стероиды и способы их применения
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
EP3868382A1 (en) 2013-07-19 2021-08-25 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
LT3488852T (lt) 2013-08-23 2021-02-25 Sage Therapeutics, Inc. Neuroaktyvūs steroidai, kompozicijos, ir jų naudojimas
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
BR112017007902B1 (pt) 2014-10-16 2023-12-05 Sage Therapeutics, Inc Composto e seu sal, composição farmacêutica e uso do referido composto e seu sal na fabricação de um medicamento para o tratamento de distúrbios do sistema nervoso central
LT3206493T (lt) 2014-10-16 2020-08-25 Sage Therapeutics, Inc. Kompozicijos ir būdai, skirti cns sutrikimams gydyti
SI3224269T1 (sl) 2014-11-27 2020-10-30 Sage Therapeutics, Inc. Sestavki in metode za zdravljenje CNS motenj
ES2857082T3 (es) 2015-01-26 2021-09-28 Sage Therapeutics Inc Composiciones y métodos para el tratamiento de trastornos del SNC
JP6875996B2 (ja) 2015-02-20 2021-05-26 セージ セラピューティクス， インコーポレイテッド 神経刺激性ステロイド、組成物、およびその使用
WO2016164763A1 (en) * 2015-04-10 2016-10-13 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
DK3481844T3 (da) 2016-07-11 2024-07-22 Sage Therapeutics Inc C7, C12 og C16 substituerede neuroaktive steroider og disses fremgangsmåder til anvendelse
MA45599A (fr) 2016-07-11 2019-05-15 Sage Therapeutics Inc Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation
EP3712161A1 (en) * 2019-03-19 2020-09-23 Bionice, S.L.U. Process for preparing high puritiy allopregnanolone and intermediates thereof
WO2020243488A1 (en) 2019-05-31 2020-12-03 Sage Therapeutics, Inc. Neuroactive steroids and compositions thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2681353A (en) * 1952-03-11 1954-06-15 Sterling Drug Inc Chlorination of keto-steroids
GB1380248A (en) * 1970-12-17 1975-01-08 Glaxo Lab Ltd 3alpha-hydroxy steroids and esters thereof

Also Published As

Publication number Publication date
NL7606137A (nl) 1976-12-14
DE2526373C2 (de) 1983-11-10
DK260976A (da) 1976-12-12
JPS51149260A (en) 1976-12-22
CH620452A5 (xx) 1980-11-28
FR2314197A1 (fr) 1977-01-07
GB1554901A (en) 1979-10-31
HU174227B (hu) 1979-11-28
DK137837B (da) 1978-05-16
US4061661A (en) 1977-12-06
JPS6146480B2 (xx) 1986-10-14
FR2314197B1 (xx) 1981-03-20
DE2526373A1 (de) 1976-12-30
DD125699A5 (xx) 1977-05-11

Similar Documents

Publication Publication Date Title
DK137837C (da) Fremgangsmaade til fremstilling af delta9(11)-5alfa-20-ketopregnener
DK87876A (da) Fremgangsmade til fremstilling af n-acyl-l-metionin
DK243176A (da) Fremgangsmade til fremstilling af polycliske forbindelser
DK113476A (da) Fremgangsmade til fremstilling af amoxicillintrihydrat
DK107876A (da) Fremgangsmade til fremstilling af thiocarbamider
DK164476A (da) Fremgangsmade til fremstilling af piperazinylpyrazinforbindelser
DK324776A (da) Fremgangsmade til fremstilling af 3-cyanoimino-3-aminopropionitriler
DK164376A (da) Fremgangsmade til fremstilling af 3,4-dihydrospiro-2h-1,3-benzoxaziner
DK150676A (da) Fremgangsmade til fremstilling af krystallinsk natrium-o-formyl-cefamandol
DK305876A (da) Fremgangsmade til fremstilling af l-pyroglutamyl-l-prolinamid
DK155598C (da) Fremgangsmaade til fremstilling af ethylchlorthioformiat
DK283476A (da) Fremgangsmade til fremstilling af beta-acylpyrroler
DK143137C (da) Fremgangsmaade til fremstilling af phosphitchlorider
DK143281C (da) Fremgangsmaade til fremstilling af phosphitchlorider
DK415576A (da) Fremgangsmade til fremstilling af krystallinsk dipilocarpiniumpamoat
DK399976A (da) Fremgangsmade til fremstilling af aralkylamider
DK194276A (da) Fremgangsmade til fremstilling af kobberphthalocyanin
DK137929C (da) Fremgangsmaade til fremstilling af delta9(11)-5alfa-d-homo-20-ketopregnener
DK141584C (da) Fremgangsmaade til fremstilling af slagseje vinylaromat-podecopolymere
DK424676A (da) Fremgangsmade til fremstilling af 2-alkylindan
DK149803C (da) Fremgangsmaade til fremstilling af 1,2-dichlorethan
DK544476A (da) Fremgangsmade til fremstilling af difluormethyl-1,2,2-trifluorethylether
DK46476A (da) Fremgangsmade til fremstilling af 5-nitrothiazolylimidazolidiner
DK49276A (da) Fremgangsmade til fremstilling af biphenylylethere
DK27076A (da) Fremgangsmade til fremstilling af bituminose overtrek

Legal Events

Date Code Title Description
PBP Patent lapsed